Kidney replacement therapy and global issues: world experience and our challenges

Authors

DOI:

https://doi.org/10.22141/2307-1257.11.1.2022.358

Keywords:

renal replacement therapy, chronic kidney disease, peritoneal dialysis, hemodialysis, quality of life

Abstract

The problem of renal replacement therapy (RRT) is relevant in today’s world due to a large number of people with chronic kidney disease (CKD). According to current data, about 10–11 % of people suffer from CKD, of which up to 5 % need RRT. Unfortunately, the number of people with CKD in the world is increasing, which determines the growing need for RRT. There are three types of RRT, namely: hemodialysis, peritoneal dialysis, and kidney transplantation. Kidney transplantation is the most effective method of RRT, but its possibilities in the world are limited. Therefore, most people receive hemo- or peritoneal dialysis. But the long-term effects of choosing a dialysis method are not always predictable. The peritoneal dialysis and hemodialysis show similar effectiveness during the first two years. Subsequent studies compa­ring the efficacy of the two methods do not provide a clear picture due to differences in patient initial parameters and differences in treatment initiation time. It is clear that peritoneal dialysis can have significant advantages in low-income countries due to the resource costs of the latter. The known benefits of peritoneal dialysis, such as flexibility of use, high quality of life, and preservation of residual renal function, increase its attractiveness, especially for young people with stage 5 CKD. The main strategies today are timely detection and prevention of CKD, control of comorbidities, as well as the development of documents and recommendations for standardization and improving the quality of renal replacement therapy.

Downloads

Download data is not yet available.

References

Bello AK, Levin A, Lunney M, et al. Global Kidney Health Atlas: A report by the International Society of Nephrology on the Global Burden of End-stage Kidney Disease and Capacity for Kidney Replacement Therapy and Conservative Care across World Countries and Regions. Brussels, Belgium: ISN; 2019. 172 p.

Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1-150.

Yang CW, Harris DCH, Luyckx VA, et al. Global case studies for chronic kidney disease/end-stage kidney disease care. Kidney Int Suppl (2011). 2020 Mar;10(1):e24-e48. doi:10.1016/j.kisu.2019.11.010.

World Kidney Day. Chronic Kidney Disease. Available from: https://www.worldkidneyday.org/facts/chronic-kidney-disease/.

Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;1165:3-15. doi:10.1007/978-981-13-8871-2_1.

GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi:10.1016/S0140-6736(20)30045-3.

Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries. Kidney Int Rep. 2019 Dec 18;5(3):263-277. doi:10.1016/j.ekir.2019.12.003.

Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action. Kidney Int Rep. 2019 Dec 23;5(3):255-262. doi:10.1016/j.ekir.2019.12.013.

McCullough PA. Anemia of cardiorenal syndrome. Kidney Int Suppl (2011). 2021 Apr;11(1):35-45. doi:10.1016/j.kisu.2020.12.001.

Luyckx VA, Smyth B, Harris DCH, Pecoits-Filho R. Dialysis funding, eligibility, procurement, and protocols in low- and middle-income settings: results from the International Society of Nephrology collection survey. Kidney Int Suppl (2011). 2020 Mar;10(1):e10-e18. doi:10.1016/j.kisu.2019.11.005.

Klinger M, Madziarska K. Mortality predictor pattern in hemodialysis and peritoneal dialysis in diabetic patients. Adv Clin Exp Med. 2019 Jan;28(1):133-135. doi:10.17219/acem/76751.

Sola L, Levin NW, Johnson DW, et al. Development of a framework for minimum and optimal safety and quality standards for hemodialysis and peritoneal dialysis. Kidney Int Suppl (2011). 2020 Mar;10(1):e55-e62. doi:10.1016/j.kisu.2019.11.009.

Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi:10.1053/j.ajkd.2016.12.004.

Javaid MM, Khan BA, Subramanian S. Peritoneal dialysis as initial dialysis modality: a viable option for late-presenting end-stage renal disease. J Nephrol. 2019 Feb;32(1):51-56. doi:10.1007/s40620-018-0485-3.

Wilkie M, Davies S. Peritoneal Dialysis in the time of COVID-19. Perit Dial Int. 2020 Jul;40(4):357-358. doi:10.1177/0896860820921657.

Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020 Jun 18;18(1):191. doi:10.1186/s12955-020-01449-2.

Swanepoel CR, McCulloch MI, Abraham G, et al. Challenges for sustainable end-stage kidney disease care in low-middle-income countries: the problem of the workforce. Kidney Int Suppl (2011). 2020 Mar;10(1):e49-e54. doi:10.1016/j.kisu.2019.11.007.

O'Connell PJ, Brown M, Chan TM, et al. The role of kidney transplantation as a component of integrated care for chronic kidney disease. Kidney Int Suppl (2011). 2020 Mar;10(1):e78-e85. doi:10.1016/j.kisu.2019.11.006.

Bello AK, Okpechi IG, Jha V, Harris DCH, Levin A, Johnson DW. Global variation in kidney care: national and regional differences in the care and management of patients with kidney failure. Kidney Int Suppl (2011). 2021 May;11(2):e1-e3. doi:10.1016/j.kisu.2020.11.003.

Hole B, Hemmelgarn B, Brown E, et al. Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. Kidney Int Suppl (2011). 2020 Mar;10(1):e86-e94. doi:10.1016/j.kisu.2019.11.008.

Ivanov DD, Mankovsky BN. Antihypertensive Treatment and Kidney Function in Routine Practice in Patients with Type 2 Diabetes Mellitus: The Results of the Prospective "The Scythian" Trial in Ukraine. Open Urology and Nephrology. 2014;7(1):71-76. doi:10.2174/1874303X01407010071.

Ivanov DD, Ivanova MD, Crestanello T. Final results of BIRCOV trial (ARB, ACEI, DRi in COVID-19). Počki. 2021;10(3):143-149. doi:10.22141/2307-1257.10.3.2021.239591.

Published

2022-05-24

How to Cite

Ivanov, D. (2022). Kidney replacement therapy and global issues: world experience and our challenges. KIDNEYS, 11(1), 40–44. https://doi.org/10.22141/2307-1257.11.1.2022.358

Issue

Section

Looking at the problem

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>